LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5

A major reason for treatment failure of cancer is acquisition of drug resistance. The specific mechanisms underlying hepatocellular carcinoma (HCC) chemoresistance need to be fully elucidated. lncRNAs involve in drug resistance in some cancers, however, the exact functions of lncRNA colon cancer-ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Chongsheng, Sun, Yurui, Li, Yang, Ma, Junli, Shi, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098857/
https://www.ncbi.nlm.nih.gov/pubmed/35552451
http://dx.doi.org/10.1038/s41598-022-11644-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098857/
https://www.ncbi.nlm.nih.gov/pubmed/35552451
http://dx.doi.org/10.1038/s41598-022-11644-4

Ejemplares similares